Neurotech International Limited (ASX: NTI) Day 2 of the IRD Invest 2021 conference.
Brian Leedman, Non-Executive Director, Neurotech International Limited (ASX: NTI), presented on Day 2 of the IRD Invest 2021 conference. In keeping with the theme of the day, Brian explained how Neurotech International Limited is conducting clinical studies to assess the neuroprotective, anti-inflammatory and neuro-modulatory activities of our proprietary NTI/Dolce cannabis strains to meet patient needs. Brian focused on the current treatments available and the work his team is doing to develop a solution for not only Autism but also MS and other inflammatory conditions.
Recorded – September 23, 2021